The angiotensin AT1 receptor antagonist, losartan, induces barrel rotation in the rat

European Journal of Pharmacology

Volumn 363, Issue 2-3, 1998, Pages 103-106

  Kawachi, Akio ^a   Miyashita, Masahide ^a   Motoya, Toshiro ^a   Yamada, Katsushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Barrel rotation; Endothelin 1; Losartan; Rat; Vasopressin

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ANGIOTENSIN 1 RECEPTOR; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; LOSARTAN; VASOPRESSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ENDOTHELIN RECEPTOR; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ROTATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; MOTOR ACTIVITY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ENDOTHELIN-1; LOSARTAN; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, ENDOTHELIN; RECEPTORS, VASOPRESSIN; VASOPRESSINS;

EID: 0032545092     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00819-X     Document Type: Article

References (18)

1. Abood L.G., Knapp R., Mitchell T., Booth H., Schwab L. Chemical requirements of vasopressins for barrel rotation convulsions and reversal by oxytocin. J. Neurosci. Res. 5:1980;191-199.
2. Chew B.H., Weaver D.F., Gross P.M. Dose-related potent brain stimulation by the neuropeptide endothelin 1 after intraventricular administration in conscious rats. Pharmacol. Biochem. Behav. 51:1995;37-47.
3. Cohn M.L., Cohn M. 'Barrel rotation' induced by somatostatin in the non-lesioned rat. Brain Res. 96:1975;138-141.
4. D'Amico M., Berrino L., Maione S., Pizzirusso A., Rossi F. Effects of L-NAME on endothelin-1-induced barrel-rolling in periaqueductal gray area of rats. Life Sci. 57:1995;PL357-PL360.
5. D'Amico M., di Filippo C., Berrino L., Rossi F. Angiotensin II, via an action at AT1 receptors, may modulate the behavioural effects of ET-1 in conscious rats. Life Sci. 59:1996;PL355-PL358.
6. 8-vasopressin treatment: involvement of neurohypophyseal peptide receptors. Pharmacol. Biochem. Behav. 47:1994;27-32.
7. Ehlers C.L., Reed T.K., Wang M., Lebrun C.J., Koob G.F. EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat. Psychopharmacology. 87:1985;430-433.
8. Grabow T.S., Gaumann D.M., Yaksh T.L. Electroencephalographic and behavioral assessment of intracerebroventricular somatostatin and a substance P analogue. Brain Res. 489:1989;223-230.
9. Gross P.M., Weaver D.F. A new experimental model of epilepsy based on the intraventricular injection of endothelin. J. Cardiovasc. Pharmacol. 22:1993;S282-S287.
10. Gross P.M., Wainman D.S., Espinosa F.J., Nag S., Weaver D.F. Cerebral hypermetabolism produced by intraventricular endothelin-1 in rats: inhibition by nimodipine. Neuropeptides. 21:1992;211-223.
11. Gross P.M., Weaver D.F., Ho L.T., Pang J.J., Edvinsson L. FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats. Neuropharmacology. 33:1994;1155-1166.
12. Katz R.J. Behavioral effects of dynorphin - a novel opioid neuropeptide. Neuropharmacology. 19:1980;801-803.
13. Maione S., D'Amico M., Berrino L., Filippelli A., Leyva J., Rossi F. Involvement of periaqueductal gray area NMDA receptors in endothelin-induced behavioural effects. Eur. J. Pharmacol. 250:1993;209-212.
14. Pellegrino, L.J., Pellegrino, A.S., Cushmann, A.J., 1979. A Stereotaxic Atlas of the Rat Brain, 2nd edn. Plenum, New York.
15. Siegl P.K.S. Discovery of losartan, the first specific non-peptide angiotensin II receptor antagonist. J. Hypertens. 11:1993;S19-S22.
16. Yamada K., Furukawa T. Barrel rotation induced by vasopressin and involvement of dopaminergic and cholinergic functions in rats. Arch. Int. Pharmacodyn. 251:1981;88-94.
17. Yamada K., Senzaki K., Komori Y., Nikai T., Sugihara H., Nabeshima T. Changes in extracellular nitrite and nitrate levels after inhibition of glial metabolism with fluorocitrate. Brain Res. 762:1997;72-78.
18. Yamamura Y., Ogawa H., Chihara T., Kondo K., Onogawa T., Nakamura S., Mori T., Tominaga M., Yabuuchi Y. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist. Science. 252:1991;572-574.